Skip to main content
NCBI home page
Cancer Immunology, Immunotherapy : CII logoLink to Cancer Immunology, Immunotherapy : CII
. 1985 Feb;19(1):28–34. doi: 10.1007/BF00199308

Influence in vitro on NK and K cell activities by cimetidine and indomethacin with and without simultaneous exposure to interferon

Per Flodgren 1,2, Hans Olov Sjögren 2
PMCID: PMC11039153  PMID: 3844972

Abstract

The histamine-2 receptor antagonist cimetidine (10−5 M) and the prostaglandin synthesis inhibitor indomethacin (10−8 M) augmented natural killer cell activity in the majority of healthy controls and patients with advanced melanoma and in a lower frequency of patients with colorectal carcinoma. Antibody-dependent cellular cytotoxicity was increased in most melanoma patients but in a lower proportion of patients with colorectal cancer. Compared with the effect of interferon the augmentation of NK- and K-cell activities was small in most patients. Cimetidine was also demonstrated to bring about a further increase in the interferon-induced NK activation of peripheral blood mononuclear cells from a majority of healthy donors and patients with melanoma. Furthermore, cimetidine augmented the interferon-induced K-cell activation of peripheral blood mononuclear cells from most patients with melanoma and colorectal cancer.

Keywords: Melanoma, Colorectal Cancer, Natural Killer Cell, Peripheral Blood Mononuclear Cell, Indomethacin

References

  • 1.Berg K, Osther K, Heron I. Production, purification and properties of human interferons. In: Stringfellow DA, editor. interferons and interferon inducers. New York: Dekker; 1980. p. 21. [Google Scholar]
  • 2.Böyum A. Separation of leukocytes from blood and bone marrow. Scand J Clin Invest. 1968;21(97):31. [PubMed] [Google Scholar]
  • 3.Faguet GB. The role of suppressor cells in the proliferative responses of chronic lymphatic leukemia lymphocytes. J Clin Invest. 1979;63:67. doi: 10.1172/JCI109280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Fischer A, Durandy A, Griscelli C. Role of prostaglandin E2 in the induction of nonspecific T lymphocyte suppressor activity. J Immunol. 1981;126:1452. [PubMed] [Google Scholar]
  • 5.Flodgren P, Borgström S, Jönsson PE, Lindström C, Sjögren HO. Metastatic malignant melanoma: Regression induced by combined treatment with interferon HuIFN-α(Le) and cimetidine. Int J Cancer. 1983;32:657. doi: 10.1002/ijc.2910320603. [DOI] [PubMed] [Google Scholar]
  • 6.Gifford RRM, Hatfield SM, Schmidtke JR. Cimetidine-induced augmentation of human lymphocyte blastogenesis by mitogen, bacterial antigen and alloantigen. Transplantation. 1980;29:143. doi: 10.1097/00007890-198002000-00011. [DOI] [PubMed] [Google Scholar]
  • 7.Goeddel DV, Yelverton E, Ullrich A, Heyneker HL, Miozzari G, Holmes W, Seeburg PH, Dull T, May L, Stebbing N, Crea R, Maeda S, McCandliss R, Sloma A, Tabor JM, Gross M, Familletti PC, Pestka S. Human leukocyte interferon produced by E. coli is biologically active. Nature. 1980;287:411. doi: 10.1038/287411a0. [DOI] [PubMed] [Google Scholar]
  • 8.Goodwin JS, Bankhurst AD, Messner RP. Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell. J Exp Med. 1977;146:1719. doi: 10.1084/jem.146.6.1719. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Herberman RB, Ortaldo JR. Natural killer cells: their role in defences against disease. Science. 1981;214:24. doi: 10.1126/science.7025208. [DOI] [PubMed] [Google Scholar]
  • 10.Herbert J, Beaudoin R, Aubin M, Fontaine M. The regulatory effect of histamine on the immune response: Characterization of the cells involved. Cell Immunol. 1980;54:49. doi: 10.1016/0008-8749(80)90188-4. [DOI] [PubMed] [Google Scholar]
  • 11.Lima M, Rocklin RE. Histamine modulates in vitro IgG production by human mononuclear cells. Cell Immunol. 1981;64:324. doi: 10.1016/0008-8749(81)90484-6. [DOI] [PubMed] [Google Scholar]
  • 12.Malmström P, Jönsson Å, Sjögren HO. Countercurrent distribution of lymphocytes from human peripheral blood in an aqueos two-phase system: II. Separation into subclasses of lymphocytes with distrinctive functions. Cell Immunol. 1980;53:51. doi: 10.1016/0008-8749(80)90424-4. [DOI] [PubMed] [Google Scholar]
  • 13.Morito T, Bankhurst AD, Williams RC. Studies on the modulation of immunoglobulin production by prostaglandins. Prostaglandins. 1980;20:383. doi: 10.1016/s0090-6980(80)80055-4. [DOI] [PubMed] [Google Scholar]
  • 14.Nair MP, Schwartz SA. Effect of histamine and histamine antagonists on natural and antibody-dependent cellular cytotoxicity of human lymphocytes in vitro. Cell Immunol. 1983;81:45. doi: 10.1016/0008-8749(83)90210-1. [DOI] [PubMed] [Google Scholar]
  • 15.Ogden BE, Hill HR. Histamine regulates lymphocyte mitogenic responses through activation of specific H1 and H2 histamine receptors. Immunology. 1980;41:107. [PMC free article] [PubMed] [Google Scholar]
  • 16.Reinherz EL, Schlossman SF. Regulation of the immune response — inducer and suppressor T-lymphocyte subsets in human beings. N Engl J Med. 1980;303:370. doi: 10.1056/NEJM198008143030704. [DOI] [PubMed] [Google Scholar]
  • 17.Rice L, Laughter AH, Twomey JJ. Three suppressor systems in human blood that modulate lymphoproliferation. J Immunol. 1979;122:991. [PubMed] [Google Scholar]
  • 18.Rocklin RE, Breard J, Gupta S, Good RA, Melmon KL. Characterization of the human blood lymphocytes that produce a histamine-induced suppressor factor. Cell Immunol. 1980;51:226. doi: 10.1016/0008-8749(80)90255-5. [DOI] [PubMed] [Google Scholar]
  • 19.Rotter V, Tranin N. Inhibition of tumor growth in syngeneic chimeric mice mediated by a depletion of suppressor T cells. Transplantation. 1975;20:68. doi: 10.1097/00007890-197507000-00011. [DOI] [PubMed] [Google Scholar]
  • 20.Ruiz-Arguelles A, Seroogy KB, Ritts RE. In vitro effect of cimetidine on human cell-mediated cytotoxicity. Cell Immunol. 1982;69:1. doi: 10.1016/0008-8749(82)90045-4. [DOI] [PubMed] [Google Scholar]
  • 21.Sjögren HO, Nilsson K, Malmström P, Axelsson B. Column separation of monocytes by adherence to gelatin beads. J Immunol Methods. 1983;56:285. doi: 10.1016/s0022-1759(83)80018-0. [DOI] [PubMed] [Google Scholar]
  • 22.Talpaz M, Medina JE, Patt YZ, Goepert H, Guillamondegui OG, Wong W, Mauligit GM. The immune-restorative effect of cimetidine administration in vivo on the local graft-versus-host reaction of cancer patients. Clin Immunol Immunopathol. 1982;24:155. doi: 10.1016/0090-1229(82)90226-4. [DOI] [PubMed] [Google Scholar]
  • 23.Vose BM. Activation of lymphocyte anti-tumor responses in man. Towards an understanding of effector cell heterogeneity? Cancer Immunol Immunother. 1984;17:73. doi: 10.1007/BF00200039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Wang SR, Zweiman B. Histamine suppression of human lymphocyte responses to mitogens. Cell Immunol. 1978;36:28. doi: 10.1016/0008-8749(78)90247-2. [DOI] [PubMed] [Google Scholar]
  • 25.Yu A, Watts H, Jaffe N, Parkman R. Concomitant presence of tumor-specific cytotoxic and inhibitor lymphocytes in patients with osteogenic sarcoma. N Engl J Med. 1977;297:121. doi: 10.1056/NEJM197707212970301. [DOI] [PubMed] [Google Scholar]

Articles from Cancer Immunology, Immunotherapy : CII are provided here courtesy of Springer

RESOURCES